Invitrogen Partners with Cytori to Offer Adipose Stem Cell Research Products
Invitrogen Corporation and Cytori Therapeutics entered into a global strategic supply and commercialization agreement to offer adipose-derived stem cell-based research products to life science researchers. Invitrogen will offer Cytori's stem cell products to broaden the understanding of adult stem cells and to discover and accelerate development of preclinical applications for adipose derived stem cells.
Adipose tissue is widely recognized as a rich source of adult stem cells. A growing number of scientists are performing adipose stem cell research accounting for more than 300 scientific papers and abstracts since the seminal scientific paper describing this cell population was published in 2001. In addition, multiple clinical trials are underway globally using adipose stem cells.
"This product offering provides life science researchers access to an important and validated stem cell population," said Joydeep Goswami, Ph.D., vice president of stem cells and regenerative medicine for Invitrogen. "Adipose derived stem cells represent an attractive cell source from which to conduct regenerative medicine research, and we are excited to enter into this partnership with Cytori, a pioneer in this field."
The new products will be complemented by Invitrogen's many reagents that are used to isolate, characterize, expand and differentiate stem cells.
Other news from the department business & finance
These products might interest you

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy

Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection

Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.